 |
 |
U.S. Microbics Inc. is a business development and holding company that acquires, develops, and deploys innovative environmental technologies for the following:
READ MORE> |
|
U.S. Microbics Inc.'s Management Team includes professionals with decades of directly applicable experience in support of the Company achieving its goals and objectives as a provider of environmentally-sound solutions that combine engineering expertise, project management experience, and training/communications skills.
 Robert C. Brehm, Chairman, CEO and President of U.S. Microbics, Inc. (OTC-BB: BUGS). Since July 1997, Mr. Brehm has served as CEO of U.S. Microbics. Mr. Brehm has a double engineering degree (Electrical Engineering and Computer Science) and an M.B.A. in Finance and Accounting from the University of California, Berkeley. Mr. Brehm has operated a chemical production facility for a Fortune 500 firm, and he has owned and operated several software companies and a finance company. Mr. Brehm understands the technical issues of the microbial technology business as well as the business, marketing, operational, and financial requirements for business success as a public company. Click here for a PDF transcript of a July 2005 webcast interview with Robert C. Brehm.
 Bruce Beattie, Chairman, CEO and President of Sub-Surface Waste Management of Delaware, Inc. (OTC-BB: SSWM), since August 2000. Mr. Beattie brings over 25 years experience in the environmental industry, providing services to the real estate, petroleum, mining, and manufacturing industries in North America. After graduating from the University of Hawaii at Manoa (BA in Economics), Mr. Beattie worked for International Minerals and Chemicals (NYSE: IGL), Vice President & Principal ENSR (AMX: ENSR) formerly Environmental Research & Technology, then founding Principal and Vice President of ESE Land Corp (NYSE:CILCORP), appointed Program Director of IT Brownfield Services Corp. (NYSE:ITX), and most recently Group Vice President of the U.S. subsidiary of Environmental Reclamation (TSE: EVM).
 Conrad Nagel, CFO of U.S. Microbics, Inc. and President of USM Capital Group, Inc. (a subsidiary of U.S. Microbics, Inc.), since August 1998. Mr. Nagel received a B.S. in Business and an M.S. in Accounting from the University of Kansas. A CPA since 1966, Mr. Nagel has been associated with SEC compliance, auditing, and finance operations for the past 30 years. His career includes having worked as Audit Manager at Deloitte-Touche; VP Finance at Decision, Inc.; Internal Audit Manager at Kaiser Aetna; CFO at Calusa Financial Medical; and VP Finance at Medical Capital Corp.
|